首页> 外文期刊>Biological & pharmaceutical bulletin >Current Status of Adverse Events Related with Opioid Analgesics in Japan: Assessment Based on Japanese Adverse Drug Event Report Database
【24h】

Current Status of Adverse Events Related with Opioid Analgesics in Japan: Assessment Based on Japanese Adverse Drug Event Report Database

机译:与日本阿片类药物镇痛药相关的不良事件的现状:基于日本不利药物事件报告数据库的评估

获取原文
获取原文并翻译 | 示例
           

摘要

Opioid analgesics have greatly contributed to the advancement of pain management. However, although opioids have been appropriately used in Japan, they rarely induce serious adverse events, such as respiratory depression. The present study aimed to investigate the temporal changes in the occurrence of opioid-related adverse events and deaths between 2004 and 2017 in Japan using the Japanese Adverse Drug Event Report (JADER) database. We analyzed the following points using data extracted from JADER website: 1) temporal changes in the number and proportion of opioid-related adverse event reports; 2) temporal changes in the number of morphine-, oxycodone-, and fentanyl-related adverse event reports per annual consumption; and 3) cases in which the reported outcome following opioid-related adverse events was death. Our results showed no dramatic changes in the overall incidence of opioid-related adverse events, despite the temporal changes in the annual consumption and shared component of each opioid during the survey period. However, the number and rate of fentanyl-related adverse events and their outcome "death" increased since 2010, being the highest among all adverse event including those related to morphine and oxycodone. Outcome "death" by fentanyl-related adverse events was caused mainly due to respiratory depression. These findings suggest that, although opioid-related adverse events can be controlled through proper monitoring and management by medical personnel in Japan, extra caution should be continuously paid for the rare but serious fentanyl-induced adverse events.
机译:阿片类镇痛药极大地促进了疼痛管理的进步。然而,虽然阿片类药物在日本适当地使用,但它们很少诱导严重的不良事件,例如呼吸抑郁症。本研究旨在使用日本不利药物事件报告(JADER)数据库,调查2004年至2017年2004年至2017年与2004年至2017年与阿片类药物相关不良事件和死亡发生的时间变化。我们使用从Jader网站提取的数据分析了以下几点:1)表阿片类相关不良事件报告的数量和比例的时间变化; 2)每年消费量的吗啡,羟考酮和芬太尼和芬太尼相关不良事件报告数量的时间变化; 3)案例,其中据报道的同学相关不良事件发生了死亡。我们的结果表明,除调查期间各阿片类药物的年消费和共同组成部分时,表述与表述相关不良事件的总发生率没有显着变化。然而,自2010年以来,芬太尼相关不良事件及其结果“死亡”的数量和率是在所有不良事件中最高的,包括与吗啡和羟考酮有关的不良事件。芬太尼相关不良事件的结果“死亡”主要是由于呼吸抑郁症。这些研究结果表明,尽管通过日本医务人员通过适当的监测和管理可以控制与阿片类相关的不良事件,但应不断支付罕见但严重的芬太尼诱导的不良事件的额外谨慎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号